| Bioactivity | Microtubule inhibitor 9 (Compound O-7) is a 2-Aryl-1H-benzo [d] imidazole derivative with in vitro anticancer activity. Microtubule inhibitor 9 can induce cell cycle arrest at the G2/M phase and early apoptosis. Microtubule inhibitor 9 inhibits cancer cell migration by inhibiting wound healing and colony formation[1]. |
| Name | Microtubule inhibitor 9 |
| Formula | C23H16N2O |
| Molar Mass | 336.39 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Park S J, et al. The microtubule cytoskeleton: A validated target for the development of 2-Aryl-1H-benzo [d] imidazole derivatives as potential anticancer agents[J]. Biomedicine & Pharmacotherapy, 2024, 171: 116106. |
Microtubule inhibitor 9
CAS: F: C23H16N2O W: 336.39
Microtubule inhibitor 9 (Compound O-7) is a 2-Aryl-1H-benzoimidazole derivative with in vitro anticancer activity. Micro
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.